David J. McClain

595 total citations
9 papers, 419 citations indexed

About

David J. McClain is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, David J. McClain has authored 9 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 4 papers in Virology and 3 papers in Molecular Biology. Recurrent topics in David J. McClain's work include Viral Infections and Vectors (4 papers), Viral Infections and Outbreaks Research (4 papers) and Poxvirus research and outbreaks (3 papers). David J. McClain is often cited by papers focused on Viral Infections and Vectors (4 papers), Viral Infections and Outbreaks Research (4 papers) and Poxvirus research and outbreaks (3 papers). David J. McClain collaborates with scholars based in United States. David J. McClain's co-authors include Alan Schmaljohn, Francis A. Ennis, John Cruz, P L Summers, Walter E. Demkowicz, Alan L. Rothman, Phillip R. Pittman, Joseph A. Mangiafico, Connie S. Schmaljohn and Stephen A. Harrison and has published in prestigious journals such as The Journal of Infectious Diseases, Vaccine and American Journal of Tropical Medicine and Hygiene.

In The Last Decade

David J. McClain

9 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David J. McClain United States 7 232 153 144 125 90 9 419
John Ballantyne United States 12 275 1.2× 59 0.4× 71 0.5× 58 0.5× 67 0.7× 14 382
S. D. K. Sempala Uganda 9 195 0.8× 131 0.9× 44 0.3× 131 1.0× 77 0.9× 17 343
Karen L. Hutchinson United States 11 591 2.5× 43 0.3× 80 0.6× 85 0.7× 206 2.3× 14 767
Daniele M. Swetnam United States 12 239 1.0× 64 0.4× 64 0.4× 231 1.8× 74 0.8× 14 388
Natalia A. Kuzmina United States 15 340 1.5× 272 1.8× 86 0.6× 76 0.6× 143 1.6× 27 587
Behzad Pourhossein Iran 9 212 0.9× 35 0.2× 109 0.8× 101 0.8× 54 0.6× 27 400
Anthony C. Wright United States 7 179 0.8× 171 1.1× 69 0.5× 138 1.1× 148 1.6× 7 544
Martin Arnold Germany 8 229 1.0× 21 0.1× 198 1.4× 59 0.5× 269 3.0× 10 695
Romy Kerber Germany 14 427 1.8× 21 0.1× 209 1.5× 128 1.0× 114 1.3× 15 669
Ramaswamy Raju United States 8 184 0.8× 30 0.2× 71 0.5× 89 0.7× 112 1.2× 12 344

Countries citing papers authored by David J. McClain

Since Specialization
Citations

This map shows the geographic impact of David J. McClain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. McClain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. McClain more than expected).

Fields of papers citing papers by David J. McClain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. McClain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. McClain. The network helps show where David J. McClain may publish in the future.

Co-authorship network of co-authors of David J. McClain

This figure shows the co-authorship network connecting the top 25 collaborators of David J. McClain. A scholar is included among the top collaborators of David J. McClain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. McClain. David J. McClain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Pittman, Phillip R., David J. McClain, Kevin Coonan, et al.. (2015). Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans. Vaccine. 34(4). 424–429. 33 indexed citations
2.
Ennis, Francis A., John Cruz, Walter E. Demkowicz, Alan L. Rothman, & David J. McClain. (2002). Primary Induction of Human CD8+Cytotoxic T Lymphocytes and Interferon‐γ–Producing T Cells after Smallpox Vaccination. The Journal of Infectious Diseases. 185(11). 1657–1659. 93 indexed citations
3.
Franz, David R., David J. McClain, David L. Hoover, et al.. (2001). Clinical Recognition and Management of Patients Exposed to Biological Warfare Agents. Clinics in Laboratory Medicine. 21(3). 435–474. 53 indexed citations
4.
McClain, David J., P L Summers, Stephen A. Harrison, Alan Schmaljohn, & Connie S. Schmaljohn. (2000). Clinical evaluation of a vaccinia-vectored Hantaan virus vaccine. Journal of Medical Virology. 60(1). 77–85. 59 indexed citations
5.
McClain, David J., Phillip R. Pittman, Helen H. Ramsburg, et al.. (1998). Immunologic Interference from Sequential Administration of Live Attenuated Alphavirus Vaccines. The Journal of Infectious Diseases. 177(3). 634–641. 79 indexed citations
6.
McClain, David J., P L Summers, William D. Pratt, Kelly J. Davis, & Gerald B. Jennings. (1997). Experimental Infection of Nonhuman Primates with Sandfly Fever Virus. American Journal of Tropical Medicine and Hygiene. 56(5). 554–560. 3 indexed citations
7.
McClain, David J., Shannon M. Harrison, Curtis Yeager, et al.. (1997). Immunologic Responses to Vaccinia Vaccines Administered by Different Parenteral Routes. The Journal of Infectious Diseases. 175(4). 756–763. 62 indexed citations
8.
McClain, David J.. (1996). Chapter 27: Smallpox. 1 indexed citations
9.
Schmaljohn, Alan & David J. McClain. (1996). Alphaviruses (Togaviridae) and Flaviviruses (Flaviviridae). Europe PMC (PubMed Central). 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026